艾迪药业
(688488)
| 流通市值：72.37亿 | | | 总市值：72.37亿 |
| 流通股本：4.21亿 | | | 总股本：4.21亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 377,619,691.63 | 422,725,438.85 | 335,339,509.95 | 337,145,466 |
| 交易性金融资产 | 95,281,566.98 | 30,146,102.56 | 106,183,637.03 | 135,226,994.87 |
| 应收票据及应收账款 | 148,660,950.36 | 156,174,691.95 | 152,031,473.62 | 165,566,947.32 |
| 其中：应收票据 | 7,769,853.48 | 28,829,134.78 | 12,890,146.59 | 17,006,391.45 |
| 应收账款 | 140,891,096.88 | 127,345,557.17 | 139,141,327.03 | 148,560,555.87 |
| 应收款项融资 | 37,437,716.24 | 6,874,888.88 | 10,893,172.4 | 12,188,866.53 |
| 预付款项 | 9,456,376.75 | 8,425,288.74 | 5,600,780.32 | 29,538,789.08 |
| 其他应收款合计 | 13,067,315.61 | 21,389,848.17 | 20,915,633.77 | 6,800,809.5 |
| 存货 | 266,391,336.81 | 271,741,947.75 | 254,971,935.86 | 244,631,202.62 |
| 其他流动资产 | 8,460,737.96 | 5,567,294.29 | 8,995,467.14 | 5,565,664.92 |
| 流动资产合计 | 956,375,692.34 | 923,045,501.19 | 894,931,610.09 | 936,664,740.84 |
| 非流动资产: | | | | |
| 长期股权投资 | 706,604.47 | 1,299,832.17 | - | - |
| 其他非流动金融资产 | 83,534,827.34 | 78,734,332.29 | 69,598,100 | 82,140,567.98 |
| 固定资产 | 409,619,723.98 | 416,738,470.28 | 424,195,808.58 | 432,623,144.58 |
| 在建工程 | 2,401,471.13 | 1,409,380.53 | 2,175,929.2 | 151,282.37 |
| 使用权资产 | 6,440,665.7 | 6,990,077.46 | 8,076,312.15 | 9,012,585.24 |
| 无形资产 | 164,891,315.24 | 170,506,891.66 | 175,465,377.26 | 111,189,264.97 |
| 开发支出 | 8,848,586.03 | 8,713,678.52 | 4,940,435.17 | 67,535,755.45 |
| 商誉 | 171,616,799.19 | 171,616,799.19 | 171,616,799.19 | 171,375,510.69 |
| 长期待摊费用 | 29,028,596.99 | 30,337,808.71 | 31,472,080.5 | 31,408,929.15 |
| 递延所得税资产 | 84,021,468.06 | 82,637,537.27 | 83,853,709.98 | 75,897,388.52 |
| 其他非流动资产 | 3,049,650 | 3,075,750 | 3,237,176.2 | 10,256,821.5 |
| 非流动资产合计 | 964,159,708.13 | 972,060,558.08 | 974,631,728.23 | 991,591,250.45 |
| 资产总计 | 1,920,535,400.47 | 1,895,106,059.27 | 1,869,563,338.32 | 1,928,255,991.29 |
| 流动负债: | | | | |
| 短期借款 | 329,155,468.07 | 280,134,871.79 | 220,504,209.85 | 214,485,433.35 |
| 应付票据及应付账款 | 122,622,355.36 | 135,820,243.8 | 113,262,305.93 | 94,848,911.96 |
| 其中：应付票据 | 24,394,729.23 | 32,327,691.34 | 24,394,310.98 | 14,882,479.52 |
| 应付账款 | 98,227,626.13 | 103,492,552.46 | 88,867,994.95 | 79,966,432.44 |
| 合同负债 | 4,376,351.18 | 9,751,471.03 | 13,082,552.61 | 7,095,602.8 |
| 应付职工薪酬 | 14,658,935.29 | 12,324,020.71 | 19,364,625.48 | 17,614,850.74 |
| 应交税费 | 9,773,349.78 | 10,210,141.91 | 7,932,207.87 | 12,283,152.05 |
| 其他应付款合计 | 81,019,171 | 82,640,082.87 | 82,170,338 | 90,608,441.8 |
| 一年内到期的非流动负债 | 111,277,436.39 | 114,629,766.14 | 173,268,842.19 | 172,062,945.09 |
| 其他流动负债 | 9,092,197.58 | 11,318,393.98 | 19,474,328.23 | 12,670,978.8 |
| 流动负债合计 | 681,975,264.65 | 656,828,992.23 | 649,059,410.16 | 621,670,316.59 |
| 非流动负债: | | | | |
| 长期借款 | 87,720,000 | 83,331,000 | 90,508,000 | 90,558,000 |
| 租赁负债 | 4,896,402.62 | 3,736,001.94 | 3,745,262.87 | 6,266,587.89 |
| 递延收益 | 46,940,325.88 | 48,338,338.97 | 49,736,352.06 | 45,018,927.92 |
| 递延所得税负债 | 10,796,157.2 | 10,408,708.36 | 9,427,038.05 | 12,146,359.04 |
| 非流动负债合计 | 150,352,885.7 | 145,814,049.27 | 153,416,652.98 | 153,989,874.85 |
| 负债合计 | 832,328,150.35 | 802,643,041.5 | 802,476,063.14 | 775,660,191.44 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 420,782,808 | 420,782,808 | 420,782,808 | 420,782,808 |
| 资本公积 | 883,622,921.25 | 883,622,921.25 | 883,622,921.25 | 891,703,345.55 |
| 其他综合收益 | 549,789.4 | 549,789.4 | 549,789.4 | 549,789.4 |
| 专项储备 | 1,039,928.66 | 1,166,627.71 | 1,286,382.54 | 1,330,700.21 |
| 盈余公积 | 9,307,578.93 | 9,307,578.93 | 9,307,578.93 | 9,307,578.93 |
| 未分配利润 | -325,463,627 | -319,072,605.28 | -334,654,581.53 | -254,391,916.47 |
| 归属于母公司股东权益合计 | 989,839,399.24 | 996,357,120.01 | 980,894,898.59 | 1,069,282,305.62 |
| 少数股东权益 | 98,367,850.88 | 96,105,897.76 | 86,192,376.59 | 83,313,494.23 |
| 股东权益合计 | 1,088,207,250.12 | 1,092,463,017.77 | 1,067,087,275.18 | 1,152,595,799.85 |
| 负债和股东权益合计 | 1,920,535,400.47 | 1,895,106,059.27 | 1,869,563,338.32 | 1,928,255,991.29 |
| 公告日期 | 2025-08-29 | 2025-04-30 | 2025-04-30 | 2024-10-31 |
| 审计意见(境内) | | | 标准无保留意见 | |